ES2062792T3 - Acidos dihidrobenzopiran-2-carboxilicos alcoxi-sustituidos y derivados de los mismos. - Google Patents

Acidos dihidrobenzopiran-2-carboxilicos alcoxi-sustituidos y derivados de los mismos.

Info

Publication number
ES2062792T3
ES2062792T3 ES91909729T ES91909729T ES2062792T3 ES 2062792 T3 ES2062792 T3 ES 2062792T3 ES 91909729 T ES91909729 T ES 91909729T ES 91909729 T ES91909729 T ES 91909729T ES 2062792 T3 ES2062792 T3 ES 2062792T3
Authority
ES
Spain
Prior art keywords
alkyl
dihidrobenzopiran
alcoxi
substituted
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91909729T
Other languages
English (en)
Inventor
Stevan Wakefield Djuric
Thomas Dale Penning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2062792T3 publication Critical patent/ES2062792T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA (I) Y A LAS ESTEREOISOMEROS Y A LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, EN DONDE R ES ALQUIL, ALQUENIL, ALQUINIL O CICLOALQUILALQUIL Y M ES 1 O 2; R1 ES ALQUIL DE ENTRE 1 Y 4 ATOMOS DE CARBONO; R2 ES HIDROGENO O ALQUIL DE ENTRE 1 Y 5 ATOMOS DE CARBONO; R4 ES ALQUIL DE ENTRE 1 Y 6 ATOMOS DE CARBONO; N ES UN ENTERO ENTRE 1 Y 5; E Y ES NH U OXIGENO. LOS COMPUESTOS DE LA FORMULA (I) SON ANTAGONISTAS DEL LEUCOTRIENO B4 Y SON UTILES COMO AGENTES ANTIINFLAMATORIOS EN EL TRATAMIENTO DE ENFERMEDADES MEDIATIZADAS POR EL LTB4.
ES91909729T 1990-05-16 1991-05-03 Acidos dihidrobenzopiran-2-carboxilicos alcoxi-sustituidos y derivados de los mismos. Expired - Lifetime ES2062792T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/524,765 US5051438A (en) 1990-05-16 1990-05-16 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use

Publications (1)

Publication Number Publication Date
ES2062792T3 true ES2062792T3 (es) 1994-12-16

Family

ID=24090593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91909729T Expired - Lifetime ES2062792T3 (es) 1990-05-16 1991-05-03 Acidos dihidrobenzopiran-2-carboxilicos alcoxi-sustituidos y derivados de los mismos.

Country Status (11)

Country Link
US (1) US5051438A (es)
EP (1) EP0528935B1 (es)
JP (1) JPH05506440A (es)
AT (1) ATE113045T1 (es)
AU (1) AU7892591A (es)
CA (1) CA2083040A1 (es)
DE (1) DE69104719T2 (es)
ES (1) ES2062792T3 (es)
IE (1) IE62204B1 (es)
PT (1) PT97649A (es)
WO (1) WO1991017989A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2185019C (en) * 1994-03-09 2000-08-08 Pfizer Limited Isoxazoline compounds as inhibitors of tnf release
WO1995032201A1 (en) * 1994-05-25 1995-11-30 G.D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-sulfonimides derivatives, their preparation and their use as leukotriene b4 antagonists
CN1160399A (zh) * 1994-10-13 1997-09-24 美国辉瑞有限公司 苯并吡喃和苯并稠合化合物、其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途
KR100232340B1 (ko) * 1994-10-13 1999-12-01 디. 제이. 우드, 스피겔 알렌 제이 류코트리엔 b4(ltb4) 길항물질로서의 벤조피란 및 벤조-축합된 화합물
IL141307A0 (en) * 1998-08-28 2002-03-10 Biomedicines Inc Method of mitigating the adverse effects of interleukin-2
CA2427610A1 (en) 2000-10-31 2002-08-08 Merck & Co., Inc. Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
US7732516B2 (en) * 2008-01-31 2010-06-08 Sabic Innovative Plastics Ip B.V. Flame retardant polyimide/polyester-polycarbonate compositions, methods of manufacture, and articles formed therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2180464B1 (es) * 1972-04-18 1974-12-20 Ugine Kuhlmann
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives

Also Published As

Publication number Publication date
DE69104719T2 (de) 1995-03-30
JPH05506440A (ja) 1993-09-22
EP0528935A1 (en) 1993-03-03
EP0528935B1 (en) 1994-10-19
IE911654A1 (en) 1991-11-20
WO1991017989A1 (en) 1991-11-28
IE62204B1 (en) 1994-12-28
ATE113045T1 (de) 1994-11-15
AU7892591A (en) 1991-12-10
PT97649A (pt) 1992-02-28
CA2083040A1 (en) 1991-11-17
US5051438A (en) 1991-09-24
DE69104719D1 (de) 1994-11-24

Similar Documents

Publication Publication Date Title
ES2069295T3 (es) Acidos dihidrobenzopiran-2-carboxilicos substituidos con alcoxi y derivados de los mismos.
ES2080334T3 (es) Antagonistas de leucotrieno b4.
KR950010888A (ko) 평활근세포 증식 및 재발협착증을 억제하는 방법
EP0896533A4 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
NO152047C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksom 5-(paradeuterofenyl)-5-fenylhydantoin
ZA909886B (en) Novel therapeutic application of fluoroquinolone derivatives
ATE113045T1 (de) Alkoxy-substituierte dihydrobenzopyran-2- carbonsäure und deren derivate.
FI831431A0 (fi) Bensotiazolinfoereningar
DE3362328D1 (en) (1-arylcyclobutyl) (heterocyclyl) methylamine compounds, their preparation and their use as therapeutic agents
NO173057C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzanilidderivater
NO803547L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenylamino-imidazolin-derivater
ES2037783T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas.
ES8504181A1 (es) Procedimiento para preparar nuevos derivados de piperidina
PT90262A (pt) Processo para a preparacao de novos derivados trienicos com estrutura cromenica
SE8400629L (sv) Basiska oximetrar
AU3087292A (en) New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them
SE8302452D0 (sv) Method for treatment of senile dementia
NZ238431A (en) ((1-arylpyrrolidin-2-yl)methyl)piperazine derivatives; pharmaceutical compositions and preparatory processes
PT87808A (pt) Procede de preparation de nouveaux derives de 1-arylsulfonyl 1,5-dihydro 2h-pirrol 2-one
DE69105618D1 (de) Derivate des 1,2,5,6-Tetrahydropyridin-3-caboxaldehydoxims, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
ES2005778A6 (es) Procedimiento para la obtencion de derivados de diisobutilxantina.
PT87818A (pt) Procede de preparation de nouveaux derives de 1-benzyl 2-oxo 5--alcoxy pyrrolidine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 528935

Country of ref document: ES